Introduction
Exposure of rat luteal or Leydig cells in vivo or in vitro to elevated concentrations of human choriogonadotropin (hCG) results in progressive loss of specific receptors and prolonged refractoriness of the cells' physiological responses to renewed hormonal stimulation (1,2). As the receptor content plays a pivotal role in controlling the sensitivity of target cells to LH or hCG, the underlying mechanisms of receptor down-regulation have been extensively studied by biochemical and morphological techniques. C~Toch-42:727-732, 1994) human, rat, porcine, and mouse luteinizing hormone (LH)/CG receptors (3-6) have been cloned recently, which has enabled elucidation of the possible changes in LHlCG receptor synthesis at the &A level during down-regulation (7-14). These studies have revealed that the loss of membrane-bound LH/CG receptor during down-regulation involves not only the removal of the preexisting cell surface receptors but also the down-regulation ofthe LHlCG receptor-specific &A species. Still, there is no general agreement on the mechanism(s) involved in the removal of preexisting receptors from the target cell surface. Most of the morphological evidence supports a mechanism that involves internalization of the receptor-hormone complexes followed by their degradation, most probably in lysosomes (15-19). Habberfield et al. (20) have also suggested that not all receptors are degraded but that at least a portion ofthem is recycled back to the cell surface. Proteolytic degradation of the complexes directly at the target cell surface has also been proposed (21) .
The morphological evidence that supports the internalization of the receptor-hormone complexes after hCG treatment has been mostly obtained by ligand-directed methods (15,16,22-24). However, the cellular fate of the receptor and bound hormone may differ during down-regulation. The availability of monoclonal antibodies (MAb) to the subunits of hCG capable of recognizing the receptor-bound hormone and a polyclonal LHICG receptor antisenun (25-27) capable of recognizing the receptor in the free and occupied forms enabled us to develop a double immunofluorescence technique to detect the receptor and bound hCG in the same ovarian tissue sections.
In the present study, this method was utilized to elucidate simultaneously the in vivo processing of the LHlCG receptor and bound hormone in the same luteal cells during hCG-induced downregulation. The double immunofluorescence method described here is simple and applicable for studying the cellular processing of other tightly associated receptor-ligand complexes as well. An earlier version of this study has been published as part of the thesis of Dr. Jouni T. Lakkakorpi (28) .
Materials and Methods
Materials. Pregnant mare serum gonadotropin (PMSG) 2500 IUlmg and hCG 5400 IUlmg were purchased from Diosynth (Oss, The Netherlands). MAb to h C a (clone INN-hCG-42) was the product of Serotec (Oxford, England). Polyclod antisera to hCG affinity-purificd rat luteal LHKG receptor have been extensively characterized previously (25-27). TIUTC (rhodamine isothiocyanate)-conjugated swine immunoglobulins to rabbit immunoglobulins and FITC (fluorescein isothiocyanate)-conjugated goat immunoglobulins to mouse immunoglobulins were obtained from Dako Immunoglobulins (Copenhagen, Denmark). Mowiol4-88 was the product of Hoechst (Franldurt am Main, Germany) and 1,4-diazabicyclo[2.2.2]octane (Dabco) the product of Sigma (St Louis, MO).
Treatment of the Experimental Animals. Female 27-day-old Sprague-
Dawley rats were injected with 40 IU of PMSG and 54 hr later with 25 IU hCG (29) and used for the experiments 7 days after the latter ueatment. The animals were reinjected via tail vein with a down-regulating dose (500 IU) of hCG and perfusion-fixed before and 2,6,12,24, or 36 hr after the reinjection through the ascending aorta with ~1 5 0 ml of 0.9% NaCI, followed immediately by 100 ml of ice-cold 4% paraformaldehyde/0.5% glutaraldehyde (in 0.1 M PB) and by about 60 ml of 4% paraformaldehyde/5% sucrose (in 0.1 M PB). The ovaries were removed, post-fixed in 4% paraformaldehyde/5% sucrose (in 0.1 M PB) for 3 hr, and washed intensively four times with PBS (pH 7.4). The fixed ovaries were immersed overnight at room temperature (RT) in 20% sucrose (in 0.1 M PB), followed by freezing in liquid nitrogen and sectioning at m8 bm with a cryotome (Cryo-cut microtome; American Optical, Buffalo, NY).
Double Immunofluorescence "ique. Figure 1 shows the principle of the double immunofluorescence technique. All the incubations were performed at 37°C in a humid chamber on sections affixed to glass slides. After blocking of the nonspecific binding sites with full porcine serum for 30-45 min at RT, the sections were incubated sequentially with a polyclonal antiserum to rat luteal LHlCG receptor (26) diluted 1:lOO and MAb to hCG0 diluted 150 for 3 hr. Both antibody dilutions contained 50% porcine serum and 0.3% Triton X-100 in PBS. The sections were washed three times (10 min each) with PBS, followed by incubation for 1.5 hr with 150 diluted TRITC-conjugated swine immunoglobulins to rabbit immunoglobulins (in PBS) containing 5% porcine serum, followed after washings by an incubation for 1.5 hr with FITC-conjugated goat immunoglobulins to mouse immunoglobulins (containing 5% porcine serum in PBS) diluted 150. The sections were washed as before and mounted with Mowiol containing 2.5% Dabco. The slides were left overnight in the dark at RT to harden the Mowiol mount and then stored in the dark at 4'C until viewed in confocal laser scanning microscopy (CUM). Identical results were obtained if the primacy antibodies were combined during incubation (data not shown). The tests for crossreactivities of the primary and secondary antibodies with different dilutions were negative. Nonspecific staining was analyzed by replacing the primary antiserum with normal rabbit serum.
Confocal Laser Scanning Microscopy. The sections were first examined in a conventional fluorescence microscope (Aristoplan; Leitz, Oberkochen, Germany) followed by scanning with a confocal laser scanning microscope (CUM) (Revision 4.0; Leica Lasertechnik, Heidelberg, Germany). Although the instrumentation contained the argonkrypton ion laser system (Omnichrome, Model No. 643-75; Chino, CA), which allows dual wavelength scanning exactly at the same time, the FITC-and TRITC-channels were measured separately. This arrangement was considered necessary to keep the overlapping information from both channels at minimum. Furthermore, FITC was scanned before TRITC to minimize possible photobleaching of the former fluorescence. The output voltage of the laser beam varied from 35-50 V for FITC and 65-80 V for TRITC. The objective magnifications used were x 40 (NA 1.30; NA, numeric aperture) or x 63 (NA 1.40). Emission light (fluorescence) was focused through a pinhole aperture having a diameter ratio of 70-90 to the photomultiplier. the voltage of which was ~6 5 0 V for FITC and W O O V for TRITC. The full field of view was scanned in square image formats of 256 x 256 pixels with a step size of 0.5 or 1 pm between the sequential optical sections. Furthermore, each optical section was averaged 16 times before the final image was produced on the monitor. The offset value of -90 was used in all experiments. Photographs were taken directly from the monitor with a camera having 35-70mm optics.
Results
The 2D pseudoimages of the optical sections from pseudopregnant rat ovarian sections immunofluorescence-stained at 0 hr for 
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unoccupied LHlCG receptors revealed specific fluorescence at the luteal cell periphery, the fluorescence intensity varying, however, among the luteal cells and around single cells (Figure 2A ). As mpected, the same section showed no specific fluorescence with the h C a MAb ( Figure 2B ). A faint intracellular fluorescence observed with both antibodies was regarded by reference to the controls as nonspecific ( Figures 3A and 3B) . The pseudo-3D plot of the intensity ofthe receptor-specific fluorescence in luteal cells using single optical sections ( Figure 4A ) confirmed the uneven distribution of the fluorescence. No hCG-specific fluorescence was detected (Figure 4B) . Staining of the ovarian section obtained at 2 hr after the injection of hCG (500 IU), for the receptor and bound hormone revealed intense receptor-and hCG-specific fluorescences at the luteal cell periphery, their distribution being uneven but virtually identical around single cells ( Figures 2C and 2D ). Co-localization of the fluorescence was further elucidated by the pseudo-3D plotting of the fluorescence intensities by CUM ( Figures 4C and 4D) and by scanning the sections in X-Z orientation (Figures 5A and  5B) . Figures SA and 5B also show that the staining reagents penetrate through the 8-10-vm cryosections. Both the receptor-specific and hormone-specific fluorescence disappeared from the periphery of the luteal cells within 36 hr at the same rate (Figures 2E-2L) . A virtually complete co-localization of the receptor-specific and hormone-specific fluorescence was observed at each time point, and no appearance of the fluorescence (Figures 4E-4L ) deep in the cell interior was recognized when the pseudo-3D plots were carried out.
Discussion
A double immunofluorescence technique was developed for a simultaneous detection of the LHlCG receptor and bound hCG in the same ovarian section. The development of this technique was possible because the polyclonal rabbit antiserum raised to rat LHlCG receptor contains antibodies that also recognize the occupied receptor (25-27). Furthermore, some of the tested mouse MAb to hCGp were capable of recognizing the receptor-bound hCG (see Figure  I for the principle of the procedure). This technique was used in conjunction with CUM to locate the LHlCG receptor in pseudopregnant rat luteal cells and to follow its cellular processing simultaneously with the bound hormone in the same luteal cells after hCG-induced down-regulation in vivo. The most remarkable ad-4 cells and those at right the intensities of the hCG-specific fluorescence. The ovaries were removed before (at 0 hr; A,B), and 2 hr (C,D), 6 hr (E.g. 12 hr  (OW, 24 hr (I,J) , or 36 hr (K.L) after treatment of the pseudopregnant rats with 500 IU hCG. Arrows indicate a portion of the plasma membrane of an adjacent luteal cell (E-H and J). (From reference 28. with permission.) vantage of this technique over the previously used immunoperoxidase technique (26, 27, (30) (31) (32) is that the receptor and hormone can be located simultaneously in the same section. Moreover, the intensities of the receptor-and hormone-specific fluorescence can be digitized and the data thereafter semiquantitatively analyzed by computerized CUM.
Our results obtained with ovarian specimens bearing free LHlCG receptor sites showed that the receptors are located on the luteal cells. This observation confirms the earlier evidence obtained by autoradiographic (22, 24) and hunoperoxidase approaches (26,27,  30-32) . The fact that the receptor-specific fluorescence distinctly varies among the luteal cells may point to differences in the LHlCG receptor number (33), which possibly causes a functional heterogeneity between them. The heterogeneity in the LH/CG receptor number in luteal cells may be accounted for by their dual origin from granulosa and theca cells. Alternatively, the maturing granulosa cells which are known to differ in their LHlCG receptor number (34) may respond to hCG stimulation with a variable extent of LHlCG receptor induction. The receptor-specific fluorescence was also unevenly distributed at the luteal cell periphery, pointing to a functional compartmentation of the cells. The fact that the receptor-and hCG-specific fluorescence co-localized and disappeared from the luteal cell surfaces in a parallel fashion within 36 hr after hCG injection, without any detectable accumulation of fluorescence deep in the cell interior with either antibody, suggests that the receptor and bound hormone are removed from the luteal cell surfaces in vivo at a very slow rate and most apparently through the same cellular pathway. A similar hypothesis has been put forward earlier based on immunoperoxidase staining of separate ovarian sections stained either for the LHlCG receptor or for bound hormone (26). but it has remained unclear whether the receptor and bound ligand disappear h o u g h the same cellular pathway, as different cells were viewed. Interestingly, a great number of the luteal cells were unstained 24 hr after the hCG injection. This may be accounted for by an initially lower receptor content or by a faster down-regulation rate in these cells.
The mechanisms responsible for the homologous down-regulation of LHlCG receptor has been studied extensively, as this process plays a key role in regulating the gonadotropin sensitivity of the gonadal cells. Recent studies using molecular biology techniques have revealed that hCG-induced down-regulation of the LH/CG receptor involves not only the removal of the preexisting receptors but also the cessation of receptor synthesis (e.g., 10J1). Internalization and subsequent delivery of the LH/CG receptor-hormone complexes to lysosomes for degradation have been proposed as major mechanisms for removal of the preexisting receptors from the target cell surface (15-18) . The evidence favoring this has been mainly deduced from studies in which primary cultures of normal gonadal cells and tumor cells were used and by observing the fate of the receptor by means of radiolabeled ligand (15-18) . The processing route and rate of the receptor may differ, however, in the cultured cells and especially in tumor cells, from that in vivo. Moreover, the cellular processing of the bound hormone may also differ from that of the receptor. Therefore, it is necessary to test the physiological relevance of the in vitro results by in vivo experimental approaches using staining procedures that make it possible to follow the fate of the receptor and bound hormone simultaneously in the same cells. Our results here do not unequivocally exclude the involvement of intemalization in the removal of LHlCG receptor-hormone complexes, but they do show that the observed rate of the disappearance of the complexes is very slow in vivo. If internalization and delivery of the receptor-hormone complexes deep within the luteal cell do occur, the receptor and bound hormone become rapidly and extensively degraded, as no distinct accumulation of fluorescence was observed with either antibody deep in the cell interior. This latter conclusion is in accordance with our earlier finding showing that no smaller receptor fragments capable of hormone or antibody binding appear in the ovarian tissue on induction of LHlCG receptor down-regulation (14).
In summary, the present results suggest that the LHlCG receptor-hormone complexes disappear from the luteal cells in vivo without detectable internalization. This conclusion is substantiated by the finding that no receptor-or hCG-specific fluorescence accumulated with time within the luteal cells during hCG-induced down-regulation.
